Sun, Jul 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Vulpes Investment Management announces launch of Vulpes Life-Sciences Fund

Thursday, March 01, 2012
Opalesque Industry Update - Over the past 12 years, the Vulpes partners have acquired significant stakes in a small number of selective, largely UK-based, life-science companies which they believe offer a huge discount to fair value.

These assets will now be offered in a fund structure for co-investment, continuing our plan to move all the partners’ significant assets into fund structures available for external investors.

Summary of Vulpes Life Sciences Fund:

• Small number of companies where IP/technology around diagnostics or drug discovery is very large compared to valuations
• Use of expert advice in proteomics to asses value
• Advise companies in business acumen to increase commercial value

“The UK venture capital market in life sciences in the UK can be very undervalued compared to the world class ideas coming out of UK universities and research institutes which has left the sector somewhat orphaned. We see great potential value in lifescience companies housing world-leading research and development and making significant advances in the treatment of a number of major diseases” said Stephen Diggle, Founder. “The Vulpes Life-Sciences Fund will focus on a select group of companies that possess significantly undervalued intellectual property in both diagnostics and discovery, and will use Vulpes’ experience and expertise to help maximize their commercial value”.

Vulpes Investment Management launched on 1st April 2011 and now has 5 funds open to investors: Long Asian Volatility and Arbitrage Fund, Russian Opportunities Fund and Testudo Fund; the Creo European Investments Fund and now the Vulpes Life Sciences Fund. The Vulpes Agricultural Fund will be added to the platform in the coming months. Corporate website:Source

(press release)

PD

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner